Clinical Trials
16 trialsNCT06989437 2026-06-05
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Pfizer
Phase 2/3 Recruiting
NCT05546476 2026-06-03
PROACC-1
Pfizer
Phase 2 Completed
NCT07565415 2026-05-04
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy
Nanfang Hospital, Southern Medical University
Phase 2 Not yet recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT04844970 2025-11-17
Anamorelin Study for Advanced Pancreatic Cancer
Lahey Clinic
Phase 2 Terminated
NCT04803305 2024-01-12
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Pfizer
Phase 1 Completed
NCT03245658 2023-12-18
The Effect of Cannabis in Pancreatic Cancer
University of Copenhagen
Phase 2 Withdrawn
NCT04299048 2023-12-14
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Pfizer
Phase 1 Completed
NCT04430842 2023-01-18
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
Phase 1 Completed
NCT02830620 2022-10-26
CHIMIOKINES
Centre Hospitalier Universitaire de Nice
Phase NA Completed
NCT00477919 2019-05-15
E-MOSAIC Electronic Tool to Monitor Symptoms
Swiss Cancer Institute
Completed
NCT02148159 2019-01-17
Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer
University of Florida
Phase NA Completed
NCT02121626 2017-11-22
FOCCUS
Royal Marsden NHS Foundation Trust
Completed
NCT00637728 2016-06-23
Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients
Par Pharmaceutical, Inc.
Phase 3 Terminated
NCT00513357 2012-12-11
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00060502 2011-05-17
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
Centocor, Inc.
Phase 2 Completed